510(k) Report

PMA · Approved

Approved

Kamra Inlay

P120023/S001PMAApproved May 12, 2016360-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Corneagen · LQE Implant, Corneal, Refractive

Approved on May 12, 2016 through premarket approval, which rests on the device’s own clinical evidence after a 360-day review.

Decided
May 12, 2016
Review
360 days
Class
Class III
Product code
LQE
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

FIG. 1 — Lineage of P120023/S001Source: FDA PMA database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LQE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All LQE devices

LQE Implant, Corneal, Refractive: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · LQE

1in 2025

2007: 12012: 12013: 12015: 12016: 42017: 42018: 42019: 12022: 12024: 12025: 1
2007high 4 (2016) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LQE

Too few LQE 510(k)s in any year since 2007 to give a median.

Recalls per year · LQE

1in 2018

2018: 1, 1 Class I
2007high 1 (2018) · low 0 (2007)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · LQE

1in 2025

2008: 12012: 22015: 162016: 372017: 1832018: 342019: 132020: 22021: 32022: 22023: 32024: 22025: 1
2007high 183 (2017) · low 0 (2007)2025

MAUDE reports naming product code LQE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—01
20090—00
20100—00
20110—00
20121—02
20131—00
20140—00
20151—016
20164—037
20174—0183
20184—1 (1)34
20191—013
20200—02
20210—03
20221—02
20230—03
20241—02
20251—01
20260—0—
Cite this page

510(k) Report. “P120023/S001: Kamra Inlay.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P120023/S001

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026